Nearly three months after Canadian generics firm Apotex was put on import alert by the US Food and Drug Administration (FDA), the agency has released the text of a Warning Letter issued to the company ...
US Food and Drug Administration (FDA) officials asserted at a 26 April Generic Drug Forum (GDF) that firms with weak quality cultures are more susceptible to submit abbreviated new drug applications ...
Fresh concerns have emerged about the platelet studies underpinning the FDA approval of ticagrelor, AstraZeneca's multibillion-dollar heart drug. A new BMJ investigation reveals data discrepancies, ...
In February 2022, Diego Miralles, then-CEO of a buzzy new biotech called Laronde, gathered his employees in the company’s shiny new Somerville, Mass., headquarters to relay some unsettling news. An ...
Fourteen years after AstraZeneca’s blood thinner Brilinta reached the market and now faces generic competition, the data that backed its original approvals around the world has been called into ...
Investigative reporting by Center for Public Integrity journalists about student homelessness and the legacy of pollution in communities of color was recognized among the best data journalism in the ...
You cannot turn your head to politely sneeze without encountering someone who isn’t a specialist in AI or a technology company that claims to have a product that uses AI to solve a significant ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Alooma, the modern data pipeline company, today announced Alooma Live, a real-time visualization tool that enables data scientists and engineers to monitor data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results